Search Drug By Letter : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

ONCOTICE

Package(a):
AMPS: 1.
Dosage(a):
See prescribing information for full details.
Prescribing Restrictions:    

Package(b):
AMPS: 3.
Dosage(b):
See prescribing information for full details.
Prescribing Restrictions:   


Indications:
Treatment of flat urothelial cell carcinoma in situ (CIS) of the bladder and as adjuvant therapy after transurethral resection (TUR) of primary or relapsing superficial papillary urothelial cell carcinoma of bladder stage Ta (grade 2 or 3) or T₁ (grade 1, 2 or 3). Only recommended for stage Ta grade 1 papillary tumors when there is judged to be a high risk of tumor recurrence. 
Maintenance treatment is indicated for all patients and consists of weekly instillation during 3 consecutive weeks at months 3, 6 and 12 after initiation of the treatment. The need for maintenance treatment every 6 months beyond the first year of treatment should be evaluated on the basis of classification and clinical response.
Contra-Indications:
See prescribing information for full details.
Special Precautions:
N/A
Side Effects:
N/A
Drug Interactions:
N/A